English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
The COVID-19 Antigen Rapid Test Self-testing Products from JOINSTART Get CE certifications
2022-02-07
The “COVID-19 Antigen Rapid Test – Anterior Nasal Swab” and the “COVID-19 Antigen Rapid Test (Colloidal Gold) – Saliva” developed independently by JOINSTAR Biomedical Technology Co., Ltd obtained the EU CE certification for self-testing on January 20th and February 2nd, issued by the CE 1434.
Becton Dickinson Acquires Spanish Clinical Flow Cytometry Firm Cytognos
2022-02-07
Becton Dickinson said on Tuesday that it has acquired Cytognos, a privately held developer of flow cytometry-based tests for hematologic cancer and blood diseases, from its parent firm Vitros.
Medix Biochemica expands its molecular diagnostics business through the acquisition of myPOLS Biotec
2022-02-07
Medix Biochemica has acquired 100 percent of the shares of myPOLS Biotec GmbH, a German manufacturer of innovative and high-quality raw materials in molecular diagnostics.
Thermo Fisher Scientific Revenues Grow 1 Percent in Q4, 22 Percent in 2021
2022-02-07
Thermo Fisher Scientific on Wednesday morning reported a 1 percent increase in fourth quarter revenues and a 22 percent rise in full-year 2021 revenues. The company also raised its revenue and earnings guidance for 2022.
The Potential of Structural Proteomics for Treating Neurodegenerative Diseases
2022-01-28
Two researchers from Skoltech and McGill University have published a review of the promising research field known as structural proteomics in the influential journal Chemical Reviews.
Danaher Q4 Revenues Rise 21 Percent
2022-01-28
Danaher reported on Thursday a 21 percent year-over-year increase in total sales for the fourth quarter, beating the consensus Wall Street estimate. For the three months ended Dec. 31, conglomerate posted $8.15 billion in total sales compared to $6.76 billion in the year-ago period. The analysts' average estimate was $7.92 billion.
iHealth Signed Orders for COVID-19 Reagents, With the Total Amount Increased to About USD 1.275 billion
2022-01-28
iHealth announced that it was disclosed in the previous announcement that the U.S. subsidiary of the company and the ACC of U.S. signed a purchase contract on ihealth coronavirus antigen home self-test OTC kit products on behalf of HHS, purchasing a total of 250 million iHealth kit products.
VIEW has been indexed in Chemical Abstracts Service (CAS) and INSPEC
2022-01-27
VIEW has been indexed in Chemical Abstracts Service (CAS) and Information Service for the Physics, Electro-technology, Computer and Control (INSPEC).
Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent
2022-01-27
Abbott reported Wednesday morning that its fourth quarter diagnostics revenues rose 3 percent year over year, largely as a result of rapid COVID-19 testing.
GE Healthcare's revenue hit by continued supply chain challenges
2022-01-27
GE's healthcare systems organic revenues in the fourth quarter declined 5%, more than offsetting 2% organic growth in pharmaceutical diagnostics. Nonetheless, Culp told investors that healthcare order demand remained strong in the quarter despite supply chain disruptions.
J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
2022-01-27
Johnson & Johnson on Tuesday projected that its Covid vaccine would generate $3 billion to $3.5 billion in sales in 2022, after posting a mixed fourth-quarter report that slightly beat on earnings estimates but missed on revenue.
Chance of “Pathogenic” Genetic Variant Causing Disease Is Relatively Low
2022-01-26
Imagine getting a positive result on a genetic test. The doctor tells you that you have a “pathogenic genetic variant,” or a DNA sequence that is known to raise the chances for getting a disease like breast cancer or diabetes.
Metagenomi Raises $175M in Series B Financing Round
2022-01-26
Gene editing company Metagenomi said on Tuesday that it has raised $175 million in a Series B financing round, bringing the total funding for the Emeryville, California-based startup to $300 million.
Medcaptain completes acquisition of Penlon, strengthening its position as a perioperative solutions provider
2022-01-26
Shenzhen, China, January 24, 2022: Medcaptain Medical Technology and Penlon, a world-renowned medical device manufacturer, formally entered into an acquisition.
Novogene: Net Profit in 2021 is Expected to Increase by 419.99%-523.99% year-on-year
2022-01-25
Recently, Novogene released the finance forecast that the net profit attributable to owners of the parent company in 2021 was 190 million to 228 million yuan, a year-on-year increase of 419.99% to 523.99%.
Total:
3519
Pages:
235
First
Prev
1
..
149
150
151
152
153
154
155
..
235
Next
End